4,616 Shares of VanEck Pharmaceutical ETF $PPH Bought by Mesirow Financial Investment Management Inc.

Mesirow Financial Investment Management Inc. purchased a new position in shares of VanEck Pharmaceutical ETF (NASDAQ:PPH) in the third quarter, according to its most recent disclosure with the SEC. The firm purchased 4,616 shares of the company’s stock, valued at approximately $505,000.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. TD Waterhouse Canada Inc. grew its stake in shares of VanEck Pharmaceutical ETF by 130.0% in the 2nd quarter. TD Waterhouse Canada Inc. now owns 230 shares of the company’s stock valued at $25,000 after buying an additional 130 shares in the last quarter. Latitude Advisors LLC bought a new position in VanEck Pharmaceutical ETF during the third quarter valued at approximately $55,000. IFP Advisors Inc raised its position in VanEck Pharmaceutical ETF by 115.7% during the second quarter. IFP Advisors Inc now owns 537 shares of the company’s stock valued at $59,000 after acquiring an additional 288 shares in the last quarter. North Star Investment Management Corp. bought a new position in VanEck Pharmaceutical ETF during the third quarter valued at approximately $64,000. Finally, Continuum Advisory LLC acquired a new stake in VanEck Pharmaceutical ETF in the second quarter valued at approximately $68,000.

VanEck Pharmaceutical ETF Stock Down 0.3%

NASDAQ PPH opened at $121.30 on Friday. The stock has a market capitalization of $1.10 billion, a PE ratio of 29.81 and a beta of 0.43. VanEck Pharmaceutical ETF has a 12-month low of $97.52 and a 12-month high of $123.53. The company has a 50 day moving average price of $113.51 and a two-hundred day moving average price of $108.61.

VanEck Pharmaceutical ETF Cuts Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, October 6th. Stockholders of record on Thursday, October 1st were issued a dividend of $0.36 per share. The ex-dividend date was Thursday, October 1st. This represents a $1.44 dividend on an annualized basis and a dividend yield of 1.2%. This is a decrease from VanEck Pharmaceutical ETF’s previous quarterly dividend of $0.6248.

About VanEck Pharmaceutical ETF

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.